type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Science Duuude -
The evolution of Hydroxychloroquine. From malarial treatment to snake oil for curing Covid. America's love affair with quackery and snake oil explored

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Mixing Covid Vaccines May Not Be a Great Idea, Research Shows

Medika Life -
Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories